The prevalence of Mycobacterium tuberculosis and rifampicin-resistance strains using GeneXpert-MTB/RIF assay in Ethiopia: a systematic review and meta-analysis
Mengistu Abayneh, Ahmed Zeynudin, Yared Alemu, Teshome Degefa, Abdulhakim Abamecha, Mulualem Tadesse, Abraham Tamirat Gizaw · 2025
Read The prevalence of Mycobacterium tuberculosis and rifampicin-resistance strains using GeneXpert-MTB/RIF assay in Ethiopia: a systematic review and meta-analysis by Mengistu Abayneh, Ahmed Zeynudin, Yared Alemu, Teshome Degefa, Abdulhakim Abamecha, Mulualem Tadesse, Abraham Tamirat Gizaw (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12801861.txt.
Description
Mengistu Abayneh and co-authors pool studies from across Ethiopia to estimate how common tuberculosis is among people tested for it. Their review, published in 2025, gathers 39 studies that used the GeneXpert test, a fast machine test that also spots strains resistant to the drug rifampicin. Past figures for the country were scattered, so a pooled estimate was needed.
Across the studies, about 15 percent of suspected patients had tuberculosis, and about 8 percent of cases resisted rifampicin. Rates were higher in people treated before, at 22 percent, and in people living with HIV, at 20 percent. Lung and other forms of the disease appeared at equal rates. The authors say the resistant share is a warning for treatment programs in the country.
Catalog record
| CREATOR | Mengistu Abayneh, Ahmed Zeynudin, Yared Alemu, Teshome Degefa, Abdulhakim Abamecha, Mulualem Tadesse, Abraham Tamirat Gizaw |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 61 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |